What makes the body absorb too much iron? - Researchers at EMBL and Harvard gain new insights into the most common inherited disease in the Western world
Researchers at EMBL and Harvard gain new insights into the
most common inherited disease in the Western world
Like most nutrients, iron is good for people in the right doses. When the
body has enough iron, our cells stop absorbing it from food; if there is too
little, they absorb more. This system breaks down in the most common inherited
disease in the Western world: hemochromatosis, which affects about one in every
250 people and is often fatal if it is not recognized and treated. Now
researchers at the European Molecular Biology Laboratory in Heidelberg (EMBL)
and Harvard Medical School (U.S.) have linked the response of a gene in the
liver to the disease. The study, which appears in the current issue of Nature
Genetics, is changing our understanding of how hemochromatosis develops.
"Untreated iron overload can result in liver cancer, heart disease, or other
fatal conditions," says Martina Muckenthaler, a staff scientist at EMBL in the
research group of Matthias Hentze. "The mutation that causes the disease was
thought to have its major effects in the intestine, where cells absorb iron from
food. Our current study has changed that picture."
Sufferers of hemochromatosis have inherited a defective copy of a gene called
Hfe from each parent. The mutation can be traced back several centuries into
Celtic history, where it originated in a single person who passed it down to his
or her children. It has now spread throughout Europe and the Western world.
The defect leads a person's intestine to absorb too much iron from his or her
diet. Over the course of many years, this builds up, and by middle age, the
overload may be very serious. Hentze and his group at EMBL have been trying to
trace these effects back to their molecular causes.
Until now, most researchers have thought that the problem stems from a faulty
intestinal signal that there is too little iron, leading cells in the intestines
to produce more transport proteins that draw iron inside.
By combining two approaches, the EMBL and Harvard teams have now rewritten
this model. Their study shows that the link between Hfe and iron is probably in
the liver, rather than the intestine.
The EMBL group was investigating iron absorption with a technology called DNA
chips. The method allows scientists to monitor how a cell's genes respond to
changes such as a raise in levels of iron. Working with the research team of
Wilhelm Ansorge, Muckenthaler put together a set of probes that could watch for
changes in 300 genes known to have some connection to iron.
Simultaneously, Nancy Andrews' group at Harvard was working on
hemochromatosis in mice which are often used to create models of human
disease. The Harvard scientists had developed strains of mice without Hfe, or
with the mutant version found in hemochromatosis. Both strains absorbed too much
iron and exhibited the symptoms of the disease.
The DNA chips were used to compare cells taken from these mice and their
healthy cousins. In the former model, cells with defective Hfe were expected to
behave like healthy mice with an iron deficiency they ought to produce more
iron-absorbing proteins in the intestine. That wasn't the case.
So the researchers started to look farther afield for other effects of mutant
Hfe. They discovered something intriguing in the liver. A molecule called
hepcidin wasn't being activated properly.
When iron levels rise in a healthy mouse, its liver produces more hepcidin,
and hepcidin acts like a hormone to reduce iron absorption by the intestine.
This didn't happen in mice with mutant or missing Hfe even when the
researchers directly injected them with iron. This was proof that Hfe is
necessary to make a connection between iron and hepcidin, and that shakes up the
old model. The importance of low hepcidin production in Hemochromatosis is
further underlined by the co-published work of the team of Sophie Vaulont at the
Cochin Institute in Paris. They were able to show that the liver does not load
iron when hepcidin is added to mice lacking the hemochromatosis gene. It means
that focus should change from the intestine to the liver where the lack of Hfe
seems to be doing the most damage.
How can hepcidin expression by the liver change iron absorption among
intestinal cells? A lot of questions remain, Muckenthaler says, but data from
the DNA chips suggest how this might be happening. Without hepcidin, the body
can't seem to put the brakes on intestinal molecule, called Cybrd1.
Normally iron atoms carry three positive charges; in that form they can't be
brought into cells. Cybrd1's job is to reduce the number of charges to two,
making iron transportable. If it were active all the time, a lot more of the
body's iron would be absorbable. When it isn't active, there is very little to
be absorbed. Hepcidin's normal function might be to lock down Cybrd1, thereby
shutting down the supply of available iron. This would make activating hepcidin
which can't happen with a mutant form of Hfe essential to stopping the flow
of iron into the body.
This spells an important shift in hemochromatosis research: scientists will
now turn their attention to the liver, in hopes of working out the details of
the circuit that connects iron, Hfe and hepcidin. It also hints strongly at a
link between the body's uptake of iron and the immune system, where hepcidin
also has a role to play.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"